Research Interests
Dr. Selaru’s research focuses on the intersection of clinical medicine, engineering, and biology. His research expertise is in the utilization of bioengineering tools to answer clinically relevant questions and to translate findings for use in the clinical setting. He established and leads the Selaru Lab, a National Institutes of Health-funded laboratory at Johns Hopkins that focuses on inflammation, fibrosis, and cancer.
The Selaru Lab specializes in drug and device development for inflammatory and malignant conditions, as well as tissue regeneration solutions. Some specific projects include drug development for fibrosis in the gastrointestinal tract, microrobot development for oral drug delivery, tissue engineering for fistulas and other tissue defects in IBD, and novel drug targeting approaches for inflammation and cancer. Dr. Selaru’s overarching goal is to deliver medical products and technologies to patients with IBD and cancer.
Titles
- Associate Professor, Medicine
- Associate Professor, Oncology
- Associate Professor, Biomedical Engineering
- Director, Meyerhoff Inflammatory Bowel Disease Center
Education
- MBA, Carey School of Business, Johns Hopkins University, 2014
- Fellowship, Gastroenterology, Johns Hopkins University, 2009
- Internal Medicine, University of Maryland Medical Center, 2006
- Medical Doctor, Carol Davila University of Medicine and Pharmacy, Bucharest, 1999